Matthew McAviney

Matthew McAviney

Director/Board Member at
Jamanda Ltd.
Finance
Consumer Services
Health Technology

Profile

Matthew McAviney is currently Director at Jamanda Ltd., Non-Executive Director at AviadoBio Ltd., and Partner at Monograph Capital Advisors (UK) LLP starting in 2026.
Formerly, Dr. McAviney was Director at Polyneuron Pharmaceuticals AG; Partner at NEA Management Co. LLC from 2018 to 2026; Principal at F-Prime, Inc. from 2013 to 2018; Senior Equity Research Associate & Biotechnology at Robert W.
Baird & Co., Inc. (Broker) from 2011 to 2012; and Associate, Health & Life Sciences Practice at Oliver, Wyman & Co. LLC from 2012 to 2013.
Education includes an undergraduate degree from The University of Chicago in 2006, a doctorate from the University of Illinois in 2011, and an MBA from the University of Chicago Booth School of Business in 2011.

Matthew McAviney active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Private Equity Investor 2026-03-31

Former positions of Matthew McAviney

CompaniesPositionEnd
Private Equity Investor 2026-03-30
Private Equity Investor 2018-05-31
Oliver, Wyman & Co. LLC
Private Equity Analyst 2013-08-31
Private Equity Analyst 2012-07-31
Director/Board Member -
See the detail of Matthew McAviney's experience

Training of Matthew McAviney

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Finance

Finance

Consumer Services

Consumer Services

Oliver, Wyman & Co. LLC

Finance

Health Technology

Finance

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Matthew McAviney